nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—KCNG3—hematopoietic system—stomach cancer	0.0168	0.0521	CbGeAlD
Dalfampridine—KCNH1—hematopoietic system—stomach cancer	0.0168	0.0521	CbGeAlD
Dalfampridine—KCNA3—hematopoietic system—stomach cancer	0.0137	0.0424	CbGeAlD
Dalfampridine—KCNB1—epithelium—stomach cancer	0.0133	0.0411	CbGeAlD
Dalfampridine—KCNA2—hematopoietic system—stomach cancer	0.0131	0.0404	CbGeAlD
Dalfampridine—KCNC3—epithelium—stomach cancer	0.0129	0.0399	CbGeAlD
Dalfampridine—KCNB1—smooth muscle tissue—stomach cancer	0.0128	0.0396	CbGeAlD
Dalfampridine—KCNS1—epithelium—stomach cancer	0.0119	0.0369	CbGeAlD
Dalfampridine—KCNG3—lymphoid tissue—stomach cancer	0.0119	0.0367	CbGeAlD
Dalfampridine—KCNH1—endocrine gland—stomach cancer	0.00967	0.0299	CbGeAlD
Dalfampridine—KCNA3—lymphoid tissue—stomach cancer	0.00966	0.0299	CbGeAlD
Dalfampridine—KCNA3—digestive system—stomach cancer	0.00954	0.0295	CbGeAlD
Dalfampridine—KCNG1—endocrine gland—stomach cancer	0.00862	0.0267	CbGeAlD
Dalfampridine—KCNS3—epithelium—stomach cancer	0.00856	0.0265	CbGeAlD
Dalfampridine—KCNA5—smooth muscle tissue—stomach cancer	0.00842	0.0261	CbGeAlD
Dalfampridine—KCNB1—endocrine gland—stomach cancer	0.00835	0.0258	CbGeAlD
Dalfampridine—KCNA5—pancreas—stomach cancer	0.00779	0.0241	CbGeAlD
Dalfampridine—KCNS3—pancreas—stomach cancer	0.00762	0.0236	CbGeAlD
Dalfampridine—KCNA2—endocrine gland—stomach cancer	0.0075	0.0232	CbGeAlD
Dalfampridine—KCND1—endocrine gland—stomach cancer	0.00717	0.0222	CbGeAlD
Dalfampridine—KCNA5—digestive system—stomach cancer	0.00665	0.0206	CbGeAlD
Dalfampridine—KCNF1—endocrine gland—stomach cancer	0.00614	0.019	CbGeAlD
Dalfampridine—KCND3—pancreas—stomach cancer	0.00579	0.0179	CbGeAlD
Dalfampridine—Balance disorder—Capecitabine—stomach cancer	0.00575	0.0165	CcSEcCtD
Dalfampridine—KCNQ1—pancreas—stomach cancer	0.00561	0.0174	CbGeAlD
Dalfampridine—KCNA5—endocrine gland—stomach cancer	0.00549	0.017	CbGeAlD
Dalfampridine—KCNA3—lymph node—stomach cancer	0.00545	0.0169	CbGeAlD
Dalfampridine—KCNA2—lymph node—stomach cancer	0.00518	0.016	CbGeAlD
Dalfampridine—KCNC4—lymph node—stomach cancer	0.00496	0.0153	CbGeAlD
Dalfampridine—Confusional state—Floxuridine—stomach cancer	0.00495	0.0143	CcSEcCtD
Dalfampridine—KCNQ2—endocrine gland—stomach cancer	0.00495	0.0153	CbGeAlD
Dalfampridine—Anaphylactic shock—Floxuridine—stomach cancer	0.00491	0.0141	CcSEcCtD
Dalfampridine—Infection—Floxuridine—stomach cancer	0.00488	0.014	CcSEcCtD
Dalfampridine—KCNS3—liver—stomach cancer	0.00485	0.015	CbGeAlD
Dalfampridine—Nervous system disorder—Floxuridine—stomach cancer	0.00482	0.0139	CcSEcCtD
Dalfampridine—Pharyngolaryngeal pain—Docetaxel—stomach cancer	0.00481	0.0138	CcSEcCtD
Dalfampridine—KCNQ1—digestive system—stomach cancer	0.00479	0.0148	CbGeAlD
Dalfampridine—Laryngeal pain—Docetaxel—stomach cancer	0.00476	0.0137	CcSEcCtD
Dalfampridine—Pharyngolaryngeal pain—Capecitabine—stomach cancer	0.00465	0.0134	CcSEcCtD
Dalfampridine—KCNQ5—lymph node—stomach cancer	0.00463	0.0143	CbGeAlD
Dalfampridine—Laryngeal pain—Capecitabine—stomach cancer	0.00461	0.0133	CcSEcCtD
Dalfampridine—KCNQ1—bone marrow—stomach cancer	0.00442	0.0137	CbGeAlD
Dalfampridine—Feeling abnormal—Floxuridine—stomach cancer	0.00405	0.0116	CcSEcCtD
Dalfampridine—KCNQ1—endocrine gland—stomach cancer	0.00396	0.0122	CbGeAlD
Dalfampridine—Confusional state—Mitomycin—stomach cancer	0.00389	0.0112	CcSEcCtD
Dalfampridine—KCNA5—lymph node—stomach cancer	0.0038	0.0118	CbGeAlD
Dalfampridine—KCNS3—lymph node—stomach cancer	0.00372	0.0115	CbGeAlD
Dalfampridine—KCND3—liver—stomach cancer	0.00369	0.0114	CbGeAlD
Dalfampridine—Chest discomfort—Docetaxel—stomach cancer	0.00367	0.0105	CcSEcCtD
Dalfampridine—Hypersensitivity—Floxuridine—stomach cancer	0.00362	0.0104	CcSEcCtD
Dalfampridine—KCNQ1—liver—stomach cancer	0.00357	0.011	CbGeAlD
Dalfampridine—Chest discomfort—Capecitabine—stomach cancer	0.00355	0.0102	CcSEcCtD
Dalfampridine—Asthenia—Floxuridine—stomach cancer	0.00353	0.0101	CcSEcCtD
Dalfampridine—Dyspnoea—Mitomycin—stomach cancer	0.00344	0.00989	CcSEcCtD
Dalfampridine—Feeling abnormal—Mitomycin—stomach cancer	0.00318	0.00914	CcSEcCtD
Dalfampridine—Vomiting—Floxuridine—stomach cancer	0.00312	0.00899	CcSEcCtD
Dalfampridine—Rash—Floxuridine—stomach cancer	0.0031	0.00891	CcSEcCtD
Dalfampridine—Dermatitis—Floxuridine—stomach cancer	0.00309	0.0089	CcSEcCtD
Dalfampridine—Headache—Floxuridine—stomach cancer	0.00308	0.00886	CcSEcCtD
Dalfampridine—Nausea—Floxuridine—stomach cancer	0.00292	0.0084	CcSEcCtD
Dalfampridine—Nasopharyngitis—Fluorouracil—stomach cancer	0.00292	0.00839	CcSEcCtD
Dalfampridine—KCND3—lymph node—stomach cancer	0.00283	0.00874	CbGeAlD
Dalfampridine—Asthenia—Mitomycin—stomach cancer	0.00277	0.00796	CcSEcCtD
Dalfampridine—KCNQ1—lymph node—stomach cancer	0.00274	0.00847	CbGeAlD
Dalfampridine—KCNH2—hematopoietic system—stomach cancer	0.00263	0.00812	CbGeAlD
Dalfampridine—Dizziness—Mitomycin—stomach cancer	0.00255	0.00733	CcSEcCtD
Dalfampridine—Infestation NOS—Fluorouracil—stomach cancer	0.00251	0.00723	CcSEcCtD
Dalfampridine—Infestation—Fluorouracil—stomach cancer	0.00251	0.00723	CcSEcCtD
Dalfampridine—Vomiting—Mitomycin—stomach cancer	0.00245	0.00705	CcSEcCtD
Dalfampridine—Urinary tract infection—Fluorouracil—stomach cancer	0.00244	0.00703	CcSEcCtD
Dalfampridine—Rash—Mitomycin—stomach cancer	0.00243	0.00699	CcSEcCtD
Dalfampridine—Dermatitis—Mitomycin—stomach cancer	0.00243	0.00699	CcSEcCtD
Dalfampridine—Headache—Mitomycin—stomach cancer	0.00242	0.00695	CcSEcCtD
Dalfampridine—Connective tissue disorder—Irinotecan—stomach cancer	0.00232	0.00666	CcSEcCtD
Dalfampridine—Nausea—Mitomycin—stomach cancer	0.00229	0.00659	CcSEcCtD
Dalfampridine—Angiopathy—Irinotecan—stomach cancer	0.00214	0.00615	CcSEcCtD
Dalfampridine—Immune system disorder—Irinotecan—stomach cancer	0.00213	0.00612	CcSEcCtD
Dalfampridine—Mediastinal disorder—Irinotecan—stomach cancer	0.00212	0.00611	CcSEcCtD
Dalfampridine—Nasopharyngitis—Docetaxel—stomach cancer	0.00211	0.00606	CcSEcCtD
Dalfampridine—Nasopharyngitis—Capecitabine—stomach cancer	0.00204	0.00587	CcSEcCtD
Dalfampridine—CYP2E1—hematopoietic system—stomach cancer	0.00202	0.00626	CbGeAlD
Dalfampridine—Back pain—Irinotecan—stomach cancer	0.00198	0.00571	CcSEcCtD
Dalfampridine—Infestation—Docetaxel—stomach cancer	0.00181	0.00522	CcSEcCtD
Dalfampridine—Infestation NOS—Docetaxel—stomach cancer	0.00181	0.00522	CcSEcCtD
Dalfampridine—Infestation—Capecitabine—stomach cancer	0.00176	0.00506	CcSEcCtD
Dalfampridine—Infestation NOS—Capecitabine—stomach cancer	0.00176	0.00506	CcSEcCtD
Dalfampridine—Urinary tract infection—Capecitabine—stomach cancer	0.00171	0.00491	CcSEcCtD
Dalfampridine—Convulsion—Fluorouracil—stomach cancer	0.0017	0.0049	CcSEcCtD
Dalfampridine—Confusional state—Irinotecan—stomach cancer	0.00169	0.00486	CcSEcCtD
Dalfampridine—KCNH2—bone marrow—stomach cancer	0.00168	0.00521	CbGeAlD
Dalfampridine—Anaphylactic shock—Irinotecan—stomach cancer	0.00167	0.00482	CcSEcCtD
Dalfampridine—Chest pain—Fluorouracil—stomach cancer	0.00167	0.00481	CcSEcCtD
Dalfampridine—Infection—Irinotecan—stomach cancer	0.00166	0.00479	CcSEcCtD
Dalfampridine—Nervous system disorder—Irinotecan—stomach cancer	0.00164	0.00472	CcSEcCtD
Dalfampridine—Confusional state—Fluorouracil—stomach cancer	0.00162	0.00465	CcSEcCtD
Dalfampridine—Anaphylactic shock—Fluorouracil—stomach cancer	0.0016	0.00461	CcSEcCtD
Dalfampridine—Connective tissue disorder—Docetaxel—stomach cancer	0.0016	0.00461	CcSEcCtD
Dalfampridine—Infection—Fluorouracil—stomach cancer	0.00159	0.00458	CcSEcCtD
Dalfampridine—Nervous system disorder—Fluorouracil—stomach cancer	0.00157	0.00452	CcSEcCtD
Dalfampridine—Hypotension—Irinotecan—stomach cancer	0.00156	0.0045	CcSEcCtD
Dalfampridine—Connective tissue disorder—Capecitabine—stomach cancer	0.00155	0.00446	CcSEcCtD
Dalfampridine—Insomnia—Irinotecan—stomach cancer	0.00151	0.00436	CcSEcCtD
Dalfampridine—KCNH2—endocrine gland—stomach cancer	0.00151	0.00467	CbGeAlD
Dalfampridine—Paraesthesia—Irinotecan—stomach cancer	0.0015	0.00433	CcSEcCtD
Dalfampridine—Hypotension—Fluorouracil—stomach cancer	0.0015	0.00431	CcSEcCtD
Dalfampridine—Dyspnoea—Irinotecan—stomach cancer	0.00149	0.00429	CcSEcCtD
Dalfampridine—Angiopathy—Docetaxel—stomach cancer	0.00148	0.00425	CcSEcCtD
Dalfampridine—Dyspepsia—Irinotecan—stomach cancer	0.00147	0.00424	CcSEcCtD
Dalfampridine—Immune system disorder—Docetaxel—stomach cancer	0.00147	0.00423	CcSEcCtD
Dalfampridine—Mediastinal disorder—Docetaxel—stomach cancer	0.00147	0.00422	CcSEcCtD
Dalfampridine—Insomnia—Fluorouracil—stomach cancer	0.00145	0.00417	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Irinotecan—stomach cancer	0.00145	0.00416	CcSEcCtD
Dalfampridine—Paraesthesia—Fluorouracil—stomach cancer	0.00144	0.00414	CcSEcCtD
Dalfampridine—Constipation—Irinotecan—stomach cancer	0.00143	0.00412	CcSEcCtD
Dalfampridine—Angiopathy—Capecitabine—stomach cancer	0.00143	0.00412	CcSEcCtD
Dalfampridine—Dyspnoea—Fluorouracil—stomach cancer	0.00143	0.00411	CcSEcCtD
Dalfampridine—Mental disorder—Docetaxel—stomach cancer	0.00143	0.00411	CcSEcCtD
Dalfampridine—Immune system disorder—Capecitabine—stomach cancer	0.00142	0.0041	CcSEcCtD
Dalfampridine—CYP2E1—lymphoid tissue—stomach cancer	0.00142	0.00441	CbGeAlD
Dalfampridine—Mediastinal disorder—Capecitabine—stomach cancer	0.00142	0.00409	CcSEcCtD
Dalfampridine—Nasopharyngitis—Epirubicin—stomach cancer	0.00142	0.00409	CcSEcCtD
Dalfampridine—Dyspepsia—Fluorouracil—stomach cancer	0.00141	0.00406	CcSEcCtD
Dalfampridine—CYP2E1—digestive system—stomach cancer	0.00141	0.00435	CbGeAlD
Dalfampridine—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.00138	0.00398	CcSEcCtD
Dalfampridine—Mental disorder—Capecitabine—stomach cancer	0.00138	0.00398	CcSEcCtD
Dalfampridine—Feeling abnormal—Irinotecan—stomach cancer	0.00138	0.00397	CcSEcCtD
Dalfampridine—Back pain—Docetaxel—stomach cancer	0.00137	0.00395	CcSEcCtD
Dalfampridine—Back pain—Capecitabine—stomach cancer	0.00133	0.00382	CcSEcCtD
Dalfampridine—Feeling abnormal—Fluorouracil—stomach cancer	0.00132	0.0038	CcSEcCtD
Dalfampridine—Nasopharyngitis—Doxorubicin—stomach cancer	0.00131	0.00378	CcSEcCtD
Dalfampridine—Infestation NOS—Methotrexate—stomach cancer	0.00131	0.00376	CcSEcCtD
Dalfampridine—Infestation—Methotrexate—stomach cancer	0.00131	0.00376	CcSEcCtD
Dalfampridine—Tremor—Capecitabine—stomach cancer	0.00129	0.0037	CcSEcCtD
Dalfampridine—Urticaria—Fluorouracil—stomach cancer	0.00127	0.00367	CcSEcCtD
Dalfampridine—Hypersensitivity—Irinotecan—stomach cancer	0.00123	0.00355	CcSEcCtD
Dalfampridine—Convulsion—Docetaxel—stomach cancer	0.00123	0.00354	CcSEcCtD
Dalfampridine—Infestation NOS—Epirubicin—stomach cancer	0.00122	0.00352	CcSEcCtD
Dalfampridine—Infestation—Epirubicin—stomach cancer	0.00122	0.00352	CcSEcCtD
Dalfampridine—Chest pain—Docetaxel—stomach cancer	0.00121	0.00347	CcSEcCtD
Dalfampridine—Asthenia—Irinotecan—stomach cancer	0.0012	0.00346	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.0012	0.00345	CcSEcCtD
Dalfampridine—Urinary tract infection—Epirubicin—stomach cancer	0.00119	0.00342	CcSEcCtD
Dalfampridine—Hypersensitivity—Fluorouracil—stomach cancer	0.00118	0.0034	CcSEcCtD
Dalfampridine—Chest pain—Capecitabine—stomach cancer	0.00117	0.00336	CcSEcCtD
Dalfampridine—Confusional state—Docetaxel—stomach cancer	0.00117	0.00336	CcSEcCtD
Dalfampridine—Anxiety—Capecitabine—stomach cancer	0.00116	0.00335	CcSEcCtD
Dalfampridine—CYP2E1—endocrine gland—stomach cancer	0.00116	0.0036	CbGeAlD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.00116	0.00334	CcSEcCtD
Dalfampridine—Anaphylactic shock—Docetaxel—stomach cancer	0.00116	0.00333	CcSEcCtD
Dalfampridine—Infection—Docetaxel—stomach cancer	0.00115	0.00331	CcSEcCtD
Dalfampridine—Nervous system disorder—Docetaxel—stomach cancer	0.00114	0.00327	CcSEcCtD
Dalfampridine—Infestation NOS—Doxorubicin—stomach cancer	0.00113	0.00326	CcSEcCtD
Dalfampridine—Infestation—Doxorubicin—stomach cancer	0.00113	0.00326	CcSEcCtD
Dalfampridine—Confusional state—Capecitabine—stomach cancer	0.00113	0.00325	CcSEcCtD
Dalfampridine—Skin disorder—Docetaxel—stomach cancer	0.00112	0.00323	CcSEcCtD
Dalfampridine—Infection—Capecitabine—stomach cancer	0.00111	0.0032	CcSEcCtD
Dalfampridine—Dizziness—Irinotecan—stomach cancer	0.00111	0.00319	CcSEcCtD
Dalfampridine—Urinary tract infection—Doxorubicin—stomach cancer	0.0011	0.00317	CcSEcCtD
Dalfampridine—Nervous system disorder—Capecitabine—stomach cancer	0.0011	0.00316	CcSEcCtD
Dalfampridine—Skin disorder—Capecitabine—stomach cancer	0.00109	0.00313	CcSEcCtD
Dalfampridine—Hypotension—Docetaxel—stomach cancer	0.00108	0.00311	CcSEcCtD
Dalfampridine—Connective tissue disorder—Epirubicin—stomach cancer	0.00108	0.00311	CcSEcCtD
Dalfampridine—Angiopathy—Methotrexate—stomach cancer	0.00107	0.00306	CcSEcCtD
Dalfampridine—Vomiting—Irinotecan—stomach cancer	0.00106	0.00306	CcSEcCtD
Dalfampridine—Immune system disorder—Methotrexate—stomach cancer	0.00106	0.00305	CcSEcCtD
Dalfampridine—Dizziness—Fluorouracil—stomach cancer	0.00106	0.00305	CcSEcCtD
Dalfampridine—Mediastinal disorder—Methotrexate—stomach cancer	0.00106	0.00304	CcSEcCtD
Dalfampridine—Rash—Irinotecan—stomach cancer	0.00106	0.00304	CcSEcCtD
Dalfampridine—Dermatitis—Irinotecan—stomach cancer	0.00105	0.00303	CcSEcCtD
Dalfampridine—Headache—Irinotecan—stomach cancer	0.00105	0.00302	CcSEcCtD
Dalfampridine—CYP2E1—liver—stomach cancer	0.00105	0.00324	CbGeAlD
Dalfampridine—Hypotension—Capecitabine—stomach cancer	0.00105	0.00301	CcSEcCtD
Dalfampridine—Insomnia—Docetaxel—stomach cancer	0.00105	0.00301	CcSEcCtD
Dalfampridine—KCNH2—lymph node—stomach cancer	0.00104	0.00323	CbGeAlD
Dalfampridine—Paraesthesia—Docetaxel—stomach cancer	0.00104	0.00299	CcSEcCtD
Dalfampridine—Dyspnoea—Docetaxel—stomach cancer	0.00103	0.00297	CcSEcCtD
Dalfampridine—Mental disorder—Methotrexate—stomach cancer	0.00103	0.00296	CcSEcCtD
Dalfampridine—Vomiting—Fluorouracil—stomach cancer	0.00102	0.00293	CcSEcCtD
Dalfampridine—Dyspepsia—Docetaxel—stomach cancer	0.00102	0.00293	CcSEcCtD
Dalfampridine—Insomnia—Capecitabine—stomach cancer	0.00101	0.00292	CcSEcCtD
Dalfampridine—Rash—Fluorouracil—stomach cancer	0.00101	0.00291	CcSEcCtD
Dalfampridine—Dermatitis—Fluorouracil—stomach cancer	0.00101	0.00291	CcSEcCtD
Dalfampridine—Paraesthesia—Capecitabine—stomach cancer	0.00101	0.0029	CcSEcCtD
Dalfampridine—Headache—Fluorouracil—stomach cancer	0.001	0.00289	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000999	0.00287	CcSEcCtD
Dalfampridine—Connective tissue disorder—Doxorubicin—stomach cancer	0.000999	0.00287	CcSEcCtD
Dalfampridine—Dyspnoea—Capecitabine—stomach cancer	0.000999	0.00287	CcSEcCtD
Dalfampridine—Angiopathy—Epirubicin—stomach cancer	0.000997	0.00287	CcSEcCtD
Dalfampridine—Nausea—Irinotecan—stomach cancer	0.000995	0.00286	CcSEcCtD
Dalfampridine—Immune system disorder—Epirubicin—stomach cancer	0.000993	0.00286	CcSEcCtD
Dalfampridine—Mediastinal disorder—Epirubicin—stomach cancer	0.00099	0.00285	CcSEcCtD
Dalfampridine—Constipation—Docetaxel—stomach cancer	0.00099	0.00285	CcSEcCtD
Dalfampridine—Back pain—Methotrexate—stomach cancer	0.000989	0.00284	CcSEcCtD
Dalfampridine—Dyspepsia—Capecitabine—stomach cancer	0.000986	0.00284	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000967	0.00278	CcSEcCtD
Dalfampridine—Mental disorder—Epirubicin—stomach cancer	0.000963	0.00277	CcSEcCtD
Dalfampridine—Constipation—Capecitabine—stomach cancer	0.000958	0.00276	CcSEcCtD
Dalfampridine—Feeling abnormal—Docetaxel—stomach cancer	0.000954	0.00274	CcSEcCtD
Dalfampridine—Nausea—Fluorouracil—stomach cancer	0.000953	0.00274	CcSEcCtD
Dalfampridine—Back pain—Epirubicin—stomach cancer	0.000925	0.00266	CcSEcCtD
Dalfampridine—Feeling abnormal—Capecitabine—stomach cancer	0.000923	0.00266	CcSEcCtD
Dalfampridine—Angiopathy—Doxorubicin—stomach cancer	0.000922	0.00265	CcSEcCtD
Dalfampridine—Immune system disorder—Doxorubicin—stomach cancer	0.000918	0.00264	CcSEcCtD
Dalfampridine—Mediastinal disorder—Doxorubicin—stomach cancer	0.000916	0.00264	CcSEcCtD
Dalfampridine—Mental disorder—Doxorubicin—stomach cancer	0.000891	0.00256	CcSEcCtD
Dalfampridine—Urticaria—Capecitabine—stomach cancer	0.00089	0.00256	CcSEcCtD
Dalfampridine—Convulsion—Methotrexate—stomach cancer	0.000886	0.00255	CcSEcCtD
Dalfampridine—Chest pain—Methotrexate—stomach cancer	0.00087	0.0025	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000864	0.00249	CcSEcCtD
Dalfampridine—Back pain—Doxorubicin—stomach cancer	0.000856	0.00246	CcSEcCtD
Dalfampridine—Hypersensitivity—Docetaxel—stomach cancer	0.000853	0.00245	CcSEcCtD
Dalfampridine—Confusional state—Methotrexate—stomach cancer	0.000841	0.00242	CcSEcCtD
Dalfampridine—Anaphylactic shock—Methotrexate—stomach cancer	0.000834	0.0024	CcSEcCtD
Dalfampridine—Asthenia—Docetaxel—stomach cancer	0.00083	0.00239	CcSEcCtD
Dalfampridine—Convulsion—Epirubicin—stomach cancer	0.000829	0.00238	CcSEcCtD
Dalfampridine—Infection—Methotrexate—stomach cancer	0.000829	0.00238	CcSEcCtD
Dalfampridine—Hypersensitivity—Capecitabine—stomach cancer	0.000826	0.00238	CcSEcCtD
Dalfampridine—Nervous system disorder—Methotrexate—stomach cancer	0.000818	0.00235	CcSEcCtD
Dalfampridine—Chest pain—Epirubicin—stomach cancer	0.000814	0.00234	CcSEcCtD
Dalfampridine—Anxiety—Epirubicin—stomach cancer	0.000812	0.00233	CcSEcCtD
Dalfampridine—Skin disorder—Methotrexate—stomach cancer	0.00081	0.00233	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000809	0.00233	CcSEcCtD
Dalfampridine—Asthenia—Capecitabine—stomach cancer	0.000804	0.00231	CcSEcCtD
Dalfampridine—Confusional state—Epirubicin—stomach cancer	0.000787	0.00226	CcSEcCtD
Dalfampridine—Anaphylactic shock—Epirubicin—stomach cancer	0.000781	0.00225	CcSEcCtD
Dalfampridine—Hypotension—Methotrexate—stomach cancer	0.00078	0.00224	CcSEcCtD
Dalfampridine—Infection—Epirubicin—stomach cancer	0.000776	0.00223	CcSEcCtD
Dalfampridine—Convulsion—Doxorubicin—stomach cancer	0.000767	0.00221	CcSEcCtD
Dalfampridine—Nervous system disorder—Epirubicin—stomach cancer	0.000766	0.0022	CcSEcCtD
Dalfampridine—Dizziness—Docetaxel—stomach cancer	0.000765	0.0022	CcSEcCtD
Dalfampridine—Skin disorder—Epirubicin—stomach cancer	0.000758	0.00218	CcSEcCtD
Dalfampridine—Insomnia—Methotrexate—stomach cancer	0.000755	0.00217	CcSEcCtD
Dalfampridine—Chest pain—Doxorubicin—stomach cancer	0.000754	0.00217	CcSEcCtD
Dalfampridine—Anxiety—Doxorubicin—stomach cancer	0.000751	0.00216	CcSEcCtD
Dalfampridine—Paraesthesia—Methotrexate—stomach cancer	0.000749	0.00216	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000748	0.00215	CcSEcCtD
Dalfampridine—Dyspnoea—Methotrexate—stomach cancer	0.000744	0.00214	CcSEcCtD
Dalfampridine—Dizziness—Capecitabine—stomach cancer	0.000741	0.00213	CcSEcCtD
Dalfampridine—Vomiting—Docetaxel—stomach cancer	0.000736	0.00212	CcSEcCtD
Dalfampridine—Dyspepsia—Methotrexate—stomach cancer	0.000734	0.00211	CcSEcCtD
Dalfampridine—Rash—Docetaxel—stomach cancer	0.00073	0.0021	CcSEcCtD
Dalfampridine—Hypotension—Epirubicin—stomach cancer	0.000729	0.0021	CcSEcCtD
Dalfampridine—Dermatitis—Docetaxel—stomach cancer	0.000729	0.0021	CcSEcCtD
Dalfampridine—Confusional state—Doxorubicin—stomach cancer	0.000728	0.0021	CcSEcCtD
Dalfampridine—Headache—Docetaxel—stomach cancer	0.000725	0.00209	CcSEcCtD
Dalfampridine—Anaphylactic shock—Doxorubicin—stomach cancer	0.000722	0.00208	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.00072	0.00207	CcSEcCtD
Dalfampridine—Infection—Doxorubicin—stomach cancer	0.000718	0.00206	CcSEcCtD
Dalfampridine—Vomiting—Capecitabine—stomach cancer	0.000712	0.00205	CcSEcCtD
Dalfampridine—Nervous system disorder—Doxorubicin—stomach cancer	0.000708	0.00204	CcSEcCtD
Dalfampridine—Rash—Capecitabine—stomach cancer	0.000707	0.00203	CcSEcCtD
Dalfampridine—Insomnia—Epirubicin—stomach cancer	0.000706	0.00203	CcSEcCtD
Dalfampridine—Dermatitis—Capecitabine—stomach cancer	0.000706	0.00203	CcSEcCtD
Dalfampridine—Headache—Capecitabine—stomach cancer	0.000702	0.00202	CcSEcCtD
Dalfampridine—Skin disorder—Doxorubicin—stomach cancer	0.000702	0.00202	CcSEcCtD
Dalfampridine—Paraesthesia—Epirubicin—stomach cancer	0.000701	0.00202	CcSEcCtD
Dalfampridine—Dyspnoea—Epirubicin—stomach cancer	0.000696	0.002	CcSEcCtD
Dalfampridine—Nausea—Docetaxel—stomach cancer	0.000687	0.00198	CcSEcCtD
Dalfampridine—Feeling abnormal—Methotrexate—stomach cancer	0.000687	0.00198	CcSEcCtD
Dalfampridine—Dyspepsia—Epirubicin—stomach cancer	0.000687	0.00198	CcSEcCtD
Dalfampridine—Hypotension—Doxorubicin—stomach cancer	0.000675	0.00194	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000674	0.00194	CcSEcCtD
Dalfampridine—Constipation—Epirubicin—stomach cancer	0.000668	0.00192	CcSEcCtD
Dalfampridine—Nausea—Capecitabine—stomach cancer	0.000666	0.00192	CcSEcCtD
Dalfampridine—Urticaria—Methotrexate—stomach cancer	0.000663	0.00191	CcSEcCtD
Dalfampridine—Insomnia—Doxorubicin—stomach cancer	0.000653	0.00188	CcSEcCtD
Dalfampridine—Paraesthesia—Doxorubicin—stomach cancer	0.000649	0.00187	CcSEcCtD
Dalfampridine—Dyspnoea—Doxorubicin—stomach cancer	0.000644	0.00185	CcSEcCtD
Dalfampridine—Feeling abnormal—Epirubicin—stomach cancer	0.000643	0.00185	CcSEcCtD
Dalfampridine—Dyspepsia—Doxorubicin—stomach cancer	0.000636	0.00183	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000624	0.00179	CcSEcCtD
Dalfampridine—Urticaria—Epirubicin—stomach cancer	0.00062	0.00178	CcSEcCtD
Dalfampridine—Constipation—Doxorubicin—stomach cancer	0.000618	0.00178	CcSEcCtD
Dalfampridine—Hypersensitivity—Methotrexate—stomach cancer	0.000615	0.00177	CcSEcCtD
Dalfampridine—Asthenia—Methotrexate—stomach cancer	0.000599	0.00172	CcSEcCtD
Dalfampridine—Feeling abnormal—Doxorubicin—stomach cancer	0.000595	0.00171	CcSEcCtD
Dalfampridine—Hypersensitivity—Epirubicin—stomach cancer	0.000575	0.00165	CcSEcCtD
Dalfampridine—Urticaria—Doxorubicin—stomach cancer	0.000574	0.00165	CcSEcCtD
Dalfampridine—Asthenia—Epirubicin—stomach cancer	0.00056	0.00161	CcSEcCtD
Dalfampridine—Dizziness—Methotrexate—stomach cancer	0.000552	0.00159	CcSEcCtD
Dalfampridine—Hypersensitivity—Doxorubicin—stomach cancer	0.000532	0.00153	CcSEcCtD
Dalfampridine—Vomiting—Methotrexate—stomach cancer	0.00053	0.00153	CcSEcCtD
Dalfampridine—Rash—Methotrexate—stomach cancer	0.000526	0.00151	CcSEcCtD
Dalfampridine—Dermatitis—Methotrexate—stomach cancer	0.000525	0.00151	CcSEcCtD
Dalfampridine—Headache—Methotrexate—stomach cancer	0.000523	0.0015	CcSEcCtD
Dalfampridine—Asthenia—Doxorubicin—stomach cancer	0.000518	0.00149	CcSEcCtD
Dalfampridine—Dizziness—Epirubicin—stomach cancer	0.000516	0.00149	CcSEcCtD
Dalfampridine—Vomiting—Epirubicin—stomach cancer	0.000496	0.00143	CcSEcCtD
Dalfampridine—Nausea—Methotrexate—stomach cancer	0.000496	0.00143	CcSEcCtD
Dalfampridine—Rash—Epirubicin—stomach cancer	0.000492	0.00142	CcSEcCtD
Dalfampridine—Dermatitis—Epirubicin—stomach cancer	0.000492	0.00141	CcSEcCtD
Dalfampridine—Headache—Epirubicin—stomach cancer	0.000489	0.00141	CcSEcCtD
Dalfampridine—Dizziness—Doxorubicin—stomach cancer	0.000478	0.00137	CcSEcCtD
Dalfampridine—Nausea—Epirubicin—stomach cancer	0.000464	0.00133	CcSEcCtD
Dalfampridine—Vomiting—Doxorubicin—stomach cancer	0.000459	0.00132	CcSEcCtD
Dalfampridine—Rash—Doxorubicin—stomach cancer	0.000455	0.00131	CcSEcCtD
Dalfampridine—Dermatitis—Doxorubicin—stomach cancer	0.000455	0.00131	CcSEcCtD
Dalfampridine—Headache—Doxorubicin—stomach cancer	0.000453	0.0013	CcSEcCtD
Dalfampridine—Nausea—Doxorubicin—stomach cancer	0.000429	0.00123	CcSEcCtD
Dalfampridine—KCNV2—Neuronal System—HRAS—stomach cancer	0.000258	0.000784	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—HRAS—stomach cancer	0.000258	0.000784	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—HRAS—stomach cancer	0.000258	0.000784	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—HRAS—stomach cancer	0.000258	0.000784	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—HRAS—stomach cancer	0.000258	0.000784	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—DPYD—stomach cancer	0.000256	0.000778	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—DPYD—stomach cancer	0.000256	0.000778	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—DPYD—stomach cancer	0.000256	0.000778	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—IL6ST—stomach cancer	0.000253	0.000769	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—IL6ST—stomach cancer	0.000253	0.000769	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ALOX5—stomach cancer	0.000247	0.00075	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—IL6—stomach cancer	0.000243	0.000738	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—DPYD—stomach cancer	0.000243	0.000737	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—SMAD4—stomach cancer	0.000241	0.000731	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—SMAD4—stomach cancer	0.000241	0.000731	CbGpPWpGaD
Dalfampridine—KCNA3—Neuronal System—HRAS—stomach cancer	0.00023	0.000698	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—MAPK1—stomach cancer	0.000229	0.000696	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—MAPK1—stomach cancer	0.000229	0.000696	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—MAPK1—stomach cancer	0.000229	0.000696	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—FYN—stomach cancer	0.000229	0.000694	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—FYN—stomach cancer	0.000229	0.000694	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTT1—stomach cancer	0.000226	0.000688	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTT1—stomach cancer	0.000226	0.000688	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTT1—stomach cancer	0.000226	0.000688	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—IL6R—stomach cancer	0.000226	0.000686	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—IL6R—stomach cancer	0.000226	0.000686	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP2A6—stomach cancer	0.000224	0.00068	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP2A6—stomach cancer	0.000224	0.00068	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP2A6—stomach cancer	0.000224	0.00068	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—MAPK1—stomach cancer	0.000223	0.000677	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—HRAS—stomach cancer	0.000219	0.000666	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—HRAS—stomach cancer	0.000219	0.000666	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AKR1C3—stomach cancer	0.000218	0.000661	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AKR1C3—stomach cancer	0.000218	0.000661	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AKR1C3—stomach cancer	0.000218	0.000661	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—MAPK1—stomach cancer	0.000217	0.000659	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—TP53—stomach cancer	0.000217	0.000658	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MMP2—stomach cancer	0.000215	0.000655	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MMP2—stomach cancer	0.000215	0.000655	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTT1—stomach cancer	0.000215	0.000652	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP2A6—stomach cancer	0.000212	0.000645	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ENO1—stomach cancer	0.000212	0.000645	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ENO1—stomach cancer	0.000212	0.000645	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ENO1—stomach cancer	0.000212	0.000645	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AKR1C3—stomach cancer	0.000206	0.000627	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—RHOA—stomach cancer	0.000204	0.00062	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—RHOA—stomach cancer	0.000204	0.00062	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL6R—stomach cancer	0.000202	0.000613	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ENO1—stomach cancer	0.000201	0.000611	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—MAPK1—stomach cancer	0.000199	0.000603	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—MAPK1—stomach cancer	0.000199	0.000603	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—IL6—stomach cancer	0.000198	0.000602	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—MAPK1—stomach cancer	0.000195	0.000591	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTT1—stomach cancer	0.000192	0.000584	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP2A6—stomach cancer	0.00019	0.000578	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—TP53—stomach cancer	0.000189	0.000575	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—ERBB2—stomach cancer	0.000189	0.000574	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—ERBB2—stomach cancer	0.000189	0.000574	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CD44—stomach cancer	0.000188	0.000572	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CD44—stomach cancer	0.000188	0.000572	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CD44—stomach cancer	0.000188	0.000572	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—CDK4—stomach cancer	0.000184	0.00056	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MET—stomach cancer	0.000184	0.00056	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—CDK4—stomach cancer	0.000184	0.00056	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MET—stomach cancer	0.000184	0.00056	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—HRAS—stomach cancer	0.000184	0.000558	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—HRAS—stomach cancer	0.000184	0.000558	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—HRAS—stomach cancer	0.000184	0.000558	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—AKR1C3—stomach cancer	0.000182	0.000554	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—IL6ST—stomach cancer	0.000181	0.000549	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—IL6ST—stomach cancer	0.000181	0.000549	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—HRAS—stomach cancer	0.000179	0.000543	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CD44—stomach cancer	0.000178	0.000542	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—MAPK1—stomach cancer	0.000176	0.000535	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—HRAS—stomach cancer	0.000174	0.000529	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—MAPK1—stomach cancer	0.000174	0.000527	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—IL6—stomach cancer	0.000173	0.000526	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PPARG—stomach cancer	0.000167	0.000509	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—PPARG—stomach cancer	0.000167	0.000509	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MMP9—stomach cancer	0.000162	0.000492	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MMP9—stomach cancer	0.000162	0.000492	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—IL6R—stomach cancer	0.000161	0.000489	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—IL6R—stomach cancer	0.000161	0.000489	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PPP2R1A—stomach cancer	0.00016	0.000486	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PPP2R1A—stomach cancer	0.00016	0.000486	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PPP2R1A—stomach cancer	0.00016	0.000486	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CXCL8—stomach cancer	0.00016	0.000486	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—HRAS—stomach cancer	0.000159	0.000484	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—HRAS—stomach cancer	0.000159	0.000484	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTP1—stomach cancer	0.000157	0.000477	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTP1—stomach cancer	0.000157	0.000477	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTP1—stomach cancer	0.000157	0.000477	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—HRAS—stomach cancer	0.000156	0.000475	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—HMOX1—stomach cancer	0.000155	0.00047	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—HMOX1—stomach cancer	0.000155	0.00047	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—HMOX1—stomach cancer	0.000155	0.00047	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP2—stomach cancer	0.000154	0.000467	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP2—stomach cancer	0.000154	0.000467	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL1B—stomach cancer	0.000153	0.000466	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PPP2R1A—stomach cancer	0.000152	0.000461	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTP1—stomach cancer	0.000149	0.000452	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—JUN—stomach cancer	0.000149	0.000452	CbGpPWpGaD
Dalfampridine—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—stomach cancer	0.000148	0.000451	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—MAPK1—stomach cancer	0.000148	0.000448	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—MAPK1—stomach cancer	0.000148	0.000448	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—HMOX1—stomach cancer	0.000147	0.000446	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—TYMS—stomach cancer	0.000146	0.000443	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—TYMS—stomach cancer	0.000146	0.000443	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—TYMS—stomach cancer	0.000146	0.000443	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—RHOA—stomach cancer	0.000146	0.000442	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—RHOA—stomach cancer	0.000146	0.000442	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—VEGFA—stomach cancer	0.000145	0.000442	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—VEGFA—stomach cancer	0.000145	0.000442	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTM1—stomach cancer	0.000144	0.000438	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTM1—stomach cancer	0.000144	0.000438	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTM1—stomach cancer	0.000144	0.000438	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—PRKCB—stomach cancer	0.000143	0.000433	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—HRAS—stomach cancer	0.000141	0.000429	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—HRAS—stomach cancer	0.000139	0.000423	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—TYMS—stomach cancer	0.000138	0.00042	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MAPK3—stomach cancer	0.000138	0.000418	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MAPK3—stomach cancer	0.000138	0.000418	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTM1—stomach cancer	0.000137	0.000415	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ERCC2—stomach cancer	0.000136	0.000412	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ERCC2—stomach cancer	0.000136	0.000412	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ERCC2—stomach cancer	0.000136	0.000412	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—ERBB2—stomach cancer	0.000135	0.000409	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—ERBB2—stomach cancer	0.000135	0.000409	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTP1—stomach cancer	0.000133	0.000405	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTP1—stomach cancer	0.000132	0.0004	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MAPK1—stomach cancer	0.000131	0.000398	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MAPK1—stomach cancer	0.000131	0.000398	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—EGFR—stomach cancer	0.000131	0.000398	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—EGFR—stomach cancer	0.000131	0.000398	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—VEGFA—stomach cancer	0.00013	0.000395	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ERCC2—stomach cancer	0.000129	0.000391	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—MTHFR—stomach cancer	0.000127	0.000387	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—MTHFR—stomach cancer	0.000127	0.000387	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—MTHFR—stomach cancer	0.000127	0.000387	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—KRAS—stomach cancer	0.000124	0.000376	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—KRAS—stomach cancer	0.000124	0.000376	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTM1—stomach cancer	0.000123	0.000372	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTM1—stomach cancer	0.000121	0.000367	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—MTHFR—stomach cancer	0.000121	0.000367	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—HRAS—stomach cancer	0.000118	0.00036	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—HRAS—stomach cancer	0.000118	0.00036	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CAV1—stomach cancer	0.000118	0.000357	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CAV1—stomach cancer	0.000118	0.000357	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CAV1—stomach cancer	0.000118	0.000357	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—APOA1—stomach cancer	0.000117	0.000356	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—APOA1—stomach cancer	0.000117	0.000356	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—APOA1—stomach cancer	0.000117	0.000356	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP9—stomach cancer	0.000116	0.000351	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP9—stomach cancer	0.000116	0.000351	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ACAD8—stomach cancer	0.000115	0.000348	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CAV1—stomach cancer	0.000111	0.000339	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—TNF—stomach cancer	0.000111	0.000338	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—APOA1—stomach cancer	0.000111	0.000338	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—HRAS—stomach cancer	0.000105	0.000319	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—HRAS—stomach cancer	0.000105	0.000319	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—VEGFA—stomach cancer	0.000104	0.000315	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—VEGFA—stomach cancer	0.000104	0.000315	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PPARG—stomach cancer	0.000103	0.000314	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PPARG—stomach cancer	0.000103	0.000314	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PPARG—stomach cancer	0.000103	0.000314	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—STAT3—stomach cancer	0.000103	0.000312	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—STAT3—stomach cancer	0.000103	0.000312	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GMPR2—stomach cancer	0.000102	0.00031	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—IL6—stomach cancer	0.000101	0.000306	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—IL6—stomach cancer	0.000101	0.000306	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MAPK3—stomach cancer	9.82e-05	0.000298	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MAPK3—stomach cancer	9.82e-05	0.000298	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PPARG—stomach cancer	9.8e-05	0.000298	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—IDH3B—stomach cancer	9.35e-05	0.000284	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SUCLG1—stomach cancer	9.35e-05	0.000284	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MAPK1—stomach cancer	9.34e-05	0.000284	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MAPK1—stomach cancer	9.34e-05	0.000284	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—EGFR—stomach cancer	9.34e-05	0.000284	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—EGFR—stomach cancer	9.34e-05	0.000284	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ALB—stomach cancer	9.29e-05	0.000282	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ALB—stomach cancer	9.29e-05	0.000282	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ALB—stomach cancer	9.29e-05	0.000282	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL6—stomach cancer	8.99e-05	0.000273	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TNF—stomach cancer	8.89e-05	0.00027	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TNF—stomach cancer	8.89e-05	0.00027	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—NOS3—stomach cancer	8.89e-05	0.00027	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—NOS3—stomach cancer	8.89e-05	0.00027	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NOS3—stomach cancer	8.89e-05	0.00027	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—KRAS—stomach cancer	8.82e-05	0.000268	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—KRAS—stomach cancer	8.82e-05	0.000268	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ALB—stomach cancer	8.81e-05	0.000268	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NDUFS1—stomach cancer	8.69e-05	0.000264	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NDUFV1—stomach cancer	8.69e-05	0.000264	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—NOS3—stomach cancer	8.43e-05	0.000256	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTGS2—stomach cancer	8.13e-05	0.000247	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTGS2—stomach cancer	8.13e-05	0.000247	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTGS2—stomach cancer	8.13e-05	0.000247	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PGLS—stomach cancer	7.74e-05	0.000235	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—BLVRB—stomach cancer	7.74e-05	0.000235	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTGS2—stomach cancer	7.71e-05	0.000234	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—HRAS—stomach cancer	7.5e-05	0.000228	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—HRAS—stomach cancer	7.5e-05	0.000228	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPAP2A—stomach cancer	7.39e-05	0.000224	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—MAPK1—stomach cancer	7.35e-05	0.000223	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—IL6—stomach cancer	7.18e-05	0.000218	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—IL6—stomach cancer	7.18e-05	0.000218	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CKB—stomach cancer	6.58e-05	0.0002	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—FBP1—stomach cancer	6.58e-05	0.0002	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CA1—stomach cancer	6.58e-05	0.0002	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NDUFA2—stomach cancer	6.58e-05	0.0002	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PLIN2—stomach cancer	6.19e-05	0.000188	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CA2—stomach cancer	6.02e-05	0.000183	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—HRAS—stomach cancer	5.9e-05	0.000179	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NT5E—stomach cancer	5.87e-05	0.000178	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PGAM1—stomach cancer	5.87e-05	0.000178	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALDH7A1—stomach cancer	5.6e-05	0.00017	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PLCE1—stomach cancer	5.6e-05	0.00017	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—UMPS—stomach cancer	5.37e-05	0.000163	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CA—stomach cancer	5e-05	0.000152	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CA—stomach cancer	5e-05	0.000152	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CA—stomach cancer	5e-05	0.000152	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PDHA1—stomach cancer	4.99e-05	0.000152	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ECHS1—stomach cancer	4.99e-05	0.000152	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CA—stomach cancer	4.74e-05	0.000144	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TYMP—stomach cancer	4.69e-05	0.000143	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—FADS1—stomach cancer	4.69e-05	0.000143	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SREBF2—stomach cancer	4.39e-05	0.000133	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—RORA—stomach cancer	4.34e-05	0.000132	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALDOB—stomach cancer	4.07e-05	0.000124	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALOX5—stomach cancer	3.78e-05	0.000115	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—DPYD—stomach cancer	3.72e-05	0.000113	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTT1—stomach cancer	3.29e-05	9.99e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP2A6—stomach cancer	3.25e-05	9.88e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKR1C3—stomach cancer	3.16e-05	9.61e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ENO1—stomach cancer	3.08e-05	9.37e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CD44—stomach cancer	2.73e-05	8.31e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPP2R1A—stomach cancer	2.32e-05	7.06e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTP1—stomach cancer	2.28e-05	6.93e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HMOX1—stomach cancer	2.25e-05	6.83e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TYMS—stomach cancer	2.12e-05	6.44e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTM1—stomach cancer	2.1e-05	6.37e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ERCC2—stomach cancer	1.97e-05	5.99e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MTHFR—stomach cancer	1.85e-05	5.63e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CAV1—stomach cancer	1.71e-05	5.19e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APOA1—stomach cancer	1.7e-05	5.18e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPARG—stomach cancer	1.5e-05	4.56e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALB—stomach cancer	1.35e-05	4.1e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NOS3—stomach cancer	1.29e-05	3.92e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTGS2—stomach cancer	1.18e-05	3.59e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CA—stomach cancer	7.27e-06	2.21e-05	CbGpPWpGaD
